Prof. Kevin Prise, chair of the ARGENT Research Supervisory Board, elected Vice-President of the US Radiation Research Society
Prof. Prise is Deputy Director of the Centre for Cancer Research and Cell Biology (CCRCB) and leads the Radiation Biology Group.
This appointment, rare for a non-US member of the Society, shows the important recognition and involvement of Prof. Prise in the fiend of radiobiology and cancer therapies.
On Kevin Prise’s invitation, Prof. Sandrine Lacombe, presented the advances of nanomedicine combined with radiation therapies, and promoted the ITN ARGENT activity and results at the 62nd Radiation Research Society Meeting 2016 in Kona, Hawaii.
More info: http://www.radres.org/